ICD-10 Coding for Hilar Lymph Nodes(C34.90, C34.90B, C34.90M)
Explore ICD-10 coding for hilar lymph nodes, including sarcoidosis and lymphadenopathy. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Hilar Lymph Nodes
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D86.1 | Sarcoidosis of lung | Use when sarcoidosis is confirmed by biopsy or clinical findings. |
|
| R59.0 | Localized enlarged lymph nodes | Use when lymphadenopathy is present without a confirmed cause. |
|
| C34.90 | Malignant neoplasm of unspecified part of bronchus or lung | Use when hilar lymph node involvement is due to lung cancer. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHilar Lymph Nodes
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hilar Lymph Nodes.
Omitting biopsy results in documentation
Impact
Clinical: Leads to misdiagnosis and inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Mitigation
Ensure biopsy results are included in all relevant documentation., Regular training on documentation standards.
Using R59.0 for confirmed sarcoidosis
Impact
Reimbursement: Incorrect coding may lead to reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use D86.1 when sarcoidosis is confirmed by biopsy.
Biopsy documentation
Impact
Lack of biopsy documentation for sarcoidosis coding.
Mitigation
Implement mandatory biopsy documentation checks.